Among new findings is the link between 12 different cancers inside the human genome that researchers hope will explain some of the key drivers of the disease.
Matthew Webster, a 34-year-old engineer from Newcastle, who has had his life changed due to targeted cancer treatments.
Mr Webster was diagnosed with a rare cancer called Angiomatoid Fibrous Histiocytoma at the age of 24.
These rare cancers make up one in five cancer deaths in Australia.
Matthew Webster and his partner are expecting their first child this month after his incredible recovery following precision oncology treatment (Supplied/Matthew Webster).
Mr Webster initially travelled to Germany for the treatment which was not available in Australia, but he was then able to access treatment back home through Professor David Thomas who founded the not-for-profit genomics organisation Omico.
